Incidental thyroid nodule

Changed by Francis Deng, 31 Jul 2019

Updates to Article Attributes

Body was changed:

Incidental thyroid nodules, sometimes called thyroid incidentalomas, are a common findingdiscrete lesions in the thyroid gland found on cross-sectional imaging, often performed without a head-and-neck indication for indications other than thyroid evaluation. They are common but occasionally represent thyroid cancer1. This article discusses the epidemiology of incidental thyroid nodules and recommendations for further evaluation.

Epidemiology

About 5% of the population will havehas a palpable thyroid nodule, withwhile autopsy rates approachingapproach 50% (often multiple nodules)2. As imaging techniques improve, the detection of incidental thyroid nodules on imaging has increased, moving closer to pathologists' pick uppickup rate rather than the bedside clinicians'3. Despite this, mortality figures associated with thyroid cancer have not matched this trend 4.

Rates on imaging

Incidental thyroid nodules are common and are identified at different rates depending on the modality:

  • extrathyroidal ultrasound (e.g. of the carotid arteries): 67% 5,6
  • CT (covering lower neck / upper mediastinum; e(e.g. CTof the neck, CT cervical spine, CTor chest): 25% 7,8
  • MRI: 18% 8
  • 18FDG-PET: <2% 9

There is also variable practice in the reporting

Risk of incidental thyroid nodules by radiologists 8,10.
Malignancy rates
malignancy

Despite the lower detection rate, around one-third of 18FDG-PET-positive nodules will be malignant 9 (due to the metabolic activity and increased uptake, often papillary thyroid cancers).

. Rates of malignancy from other cross-sectional modalities (CT/MRI) only reach 12% in some studies 8,11. Ultrasound is lower still at <2% onmalignancy in a population-based study, illustrating the high proportion of benign nodules 12.

CT and MRI lack the spatial resolution to characterise suspicious features, with limited correlation with US findings (including the number of nodules). Size, however, can be used to stratify follow up.

Multinodular goitres can have similar malignancy rates as solitary thyroid nodules, but typically still require ultrasound analysis to identify the highest grade (not necessarily the largest) nodule 1.

Thyroid nodules in younger patients have a higher risk of malignancy.

The incidence of thyroid cancer has increased in recent decades without a change in thyroid cancer mortality rates, suggesting an "epidemic of diagnosis" 4.

WhatManagement

There is variable practice in radiologists' reporting of incidental thyroid nodules 8,10. Professional organizations have developed recommendations in recent years to do with incidentalaid radiologists and other clinicians in their management.

Incidental thyroid nodules on CT/MRI/PET

CT, MRI, PET, and other nuclear medicine scans lack the spatial resolution to characterise suspicious features and do not perfectly agree with the size and number of nodules found on US 16. Size on CT or MRI, however, can be used to stratify need for evaluation.

American Thyroid Association recommendations

The American Thyroid Association published its guidelines on thyroid nodule management in 2015, recommending an ultrasound assessmentthyroid US for all patients in whom another imaging study suggested the presence of all nodules >10 mm detected on cross-sectional imaginga thyroid nodule 13. The guidelines also state separately that in general, only nodules >1 cm merit evaluation.

The 2015 ACR White Paper stratified incidentalWith the finding of a thyroid nodule assessment using>1 cm, a serum thyroid-stimulating hormone (TSH, thyrotropin) level should also be obtained. If the Duke 3-tiered system14:

  • category 1:
    • focally avid on PETlevel is low, locally invasive nodules, suspicious lymph nodes (cystic, calcified, enhancing)
    • US workup for any sizea radionuclide thyroid scan should be obtained.

      The findings

      of nodule
  • category 2:
    • solitary nodule in a young patient (<35 years)
    • US if ≥10 mm in adults, US for any size in paediatrics
  • category 3:
    • solitary nodule in an older adult (≥35 years)
    • US if ≥15 mm

NB: multiple nodules can be prioritised bythese tests then help guide the same characteristics.

Younger patients are at higher risk of malignancy, hence the lower size criterion. PET avid lesions also meritneed for fine needle aspiration cytology (FNAC) given, the higher proportionmost accurate method of malignancyevaluating thyroid nodules.

American College of Radiology recommendations

Small non-suspicious nodules can be includedThe American College of Radiology Incidental Thyroid Findings Committee published a white paper in the report text, but should not appear in2015 with recommendations based on the conclusion and do not requireso-called 3-tiered system initially developed at Duke University 14. A nodule meeting any of the following criteria is recommended for further evaluation by thyroid US:

  • focal thyroid uptake on FDG-PET or other nuclear medicine scans (e.g. If known significant co-morbidities/limitedoctreotide, sestamibi)
  • thyroid nodule with local tissue invasion
  • thyroid nodule with suspicious lymph nodes (enlarged, cystic, calcified, or hyperenhancing)
  • thyroid nodule ≥1 cm (in axial plane) in patients <35 years old
  • thyroid nodule ≥1.5 cm (in axial plane) in patients ≥35 years old

When multiple thyroid nodules are present, the criteria apply to the largest nodule.

Patients who have limited life expectancy this can also be considered before recommending assessment.

Whator serious comorbidities (that increase the risk of treatment or pose more risk to do withthe patient than possible thyroid cancer) should not undergo further evaluation of incidental thyroid nodules on extrathyroidal ultrasound

The same cut-off criteria are usedlacking suspicion for cross-sectional imaging (10 mm for <35 years, 15 mm for ≥35 years). Suspicious sonographic features which necessitate repeat assessment included inlocal invasion or nodal metastases unless the ACR White Paper have been updated on the ACR TI-RADS 2017 publication 15patient or referring physician specifically requests so.

Clinical impact

The Duke 3-tiered system has been found to reduce the number of incidental thyroid nodules requiring further evaluationbiopsy by one-third to nearly halfone-half compared with standard practicepractices, with only 1%a false negative rate of potential (low-grade) malignancies missed 13% 14,1617-19. There can

Incidental thyroid nodules on extrathyroidal ultrasound

Per the American College of Radiology White Paper recommendations, the same size cutoffs used for nonsonographic imaging also apply for extrathyroidal ultrasound:

  • ≥1.0 cm for age <35 years
  • ≥1.5 cm for age ≥35 years.

Dedicated thyroid ultrasound would also be a measurement discordance between modalities (with CT/MRI +/- 4.7 mm comparedindicated if suspicious features happen to US), but without any missed malignancies applyingbe captured on the Duke 3-tiered systemnonthyroidal ultrasound, such as

  • microcalcifications
  • marked hypoechogenicity
  • lobulated/irregular margins
  • taller-than-wide shape

The list of suspicious sonographic features been updated in the ACR TI-RADS 2017 publication 1715.

  • -<p><strong>Incidental thyroid nodules</strong> are a common finding in cross-sectional imaging, often performed without a head-and-neck indication <sup>1</sup>. About 5% of the population will have a palpable thyroid nodule, with autopsy rates approaching 50% (often multiple) <sup>2</sup>. As techniques improve, the detection of incidental thyroid nodules on imaging has increased moving closer to pathologists' pick up rate rather than the clinicians' <sup>3</sup>. Despite this, mortality figures associated with thyroid cancer have not matched this trend <sup>4</sup>.</p><h4>Rates on imaging</h4><p>Incidental thyroid nodules are common and are identified at different rates depending on the modality:</p><ul>
  • -<li>extrathyroidal ultrasound: 67% <sup>5,6</sup>
  • +<p><strong>Incidental thyroid nodules</strong>, sometimes called <strong>thyroid incidentalomas</strong>, are discrete lesions in the <a href="/articles/thyroid-gland">thyroid gland</a> found on cross-sectional imaging performed for indications other than thyroid evaluation. They are common but occasionally represent <a href="/articles/thyroid-malignancies">thyroid cancer</a> <sup>1</sup>. This article discusses the epidemiology of incidental thyroid nodules and recommendations for further evaluation.</p><h4>Epidemiology</h4><p>About 5% of the population has a palpable thyroid nodule, while autopsy rates approach 50% (often multiple nodules) <sup>2</sup>. As imaging techniques improve, the detection of incidental thyroid nodules has increased, moving closer to pathologists' pickup rate rather than the bedside clinicians' <sup>3</sup>. </p><p>Incidental thyroid nodules are identified at different rates depending on the modality:</p><ul>
  • +<li>extrathyroidal ultrasound (e.g. of the carotid arteries): 67% <sup>5,6</sup>
  • -<li>CT (covering lower neck / upper mediastinum; e.g. CT neck, CT cervical spine, CT chest): 25% <sup>7,8</sup>
  • +<li>CT (e.g. of the neck, cervical spine, or chest): 25% <sup>7,8</sup>
  • -<sup>18</sup>FDG-PET: &lt;2% <sup>9</sup>
  • +<a href="/articles/positron-emission-tomography"><sup>18</sup>FDG-PET</a>: &lt;2% <sup>9</sup>
  • -</ul><p>There is also variable practice in the reporting of incidental thyroid nodules by radiologists <sup>8,10</sup>.</p><h5>Malignancy rates</h5><p>Despite the lower detection rate, around one-third of <sup>18</sup>FDG-PET-positive nodules will be malignant <sup>9</sup> (due to the metabolic activity and increased uptake, often papillary thyroid cancers).</p><p>Rates of malignancy from other cross-sectional modalities (CT/MRI) only reach 12% in some studies <sup>8,11</sup>. Ultrasound is lower still at &lt;2% on a population-based study, illustrating the high proportion of benign nodules <sup>12</sup>.</p><p>CT and MRI lack the spatial resolution to characterise suspicious features, with limited correlation with US findings (including the number of nodules). Size, however, can be used to stratify follow up.</p><p>Multinodular goitres can have similar malignancy rates as solitary thyroid nodules, but typically still require ultrasound analysis to identify the highest grade (not necessarily the largest) nodule <sup>1</sup>.</p><h4>What to do with incidental thyroid nodules on CT/MRI/PET</h4><p>The American Thyroid Association published its guidelines on thyroid nodule management in 2015, recommending an ultrasound assessment of all nodules &gt;10 mm detected on cross-sectional imaging <sup>13</sup>.</p><p>The 2015 ACR White Paper stratified incidental thyroid nodule assessment using the <strong>Duke 3-tiered system</strong> <sup>14</sup>:</p><ul>
  • -<li>
  • -<strong>category 1:</strong><ul>
  • -<li>focally avid on PET, locally invasive nodules, suspicious lymph nodes (cystic, calcified, enhancing)</li>
  • -<li>US workup for any size of nodule</li>
  • -</ul>
  • -</li>
  • -<li>
  • -<strong>category 2:</strong><ul>
  • -<li>solitary nodule in a young patient (&lt;35 years)</li>
  • -<li>US if ≥10 mm in adults, US for any size in paediatrics</li>
  • -</ul>
  • -</li>
  • -<li>
  • -<strong>category 3:</strong><ul>
  • -<li>solitary nodule in an older adult (≥35 years)</li>
  • -<li>US if ≥15 mm</li>
  • -</ul>
  • -</li>
  • -</ul><p>NB: multiple nodules can be prioritised by the same characteristics.</p><p>Younger patients are at higher risk of malignancy, hence the lower size criterion. PET avid lesions also merit fine needle aspiration cytology (FNAC) given the higher proportion of malignancy.</p><p>Small non-suspicious nodules can be included in the report text, but should not appear in the conclusion and do not require any further evaluation. If known significant co-morbidities/limited life expectancy this can also be considered before recommending assessment.</p><h4>What to do with incidental thyroid nodules on extrathyroidal ultrasound</h4><p>The same cut-off criteria are used for cross-sectional imaging (10 mm for &lt;35 years, 15 mm for ≥35 years). Suspicious sonographic features which necessitate repeat assessment included in the ACR White Paper have been updated on the <a href="/articles/acr-thyroid-imaging-reporting-and-data-system-acr-ti-rads">ACR TI-RADS</a> 2017 publication <sup>15</sup>.</p><h4>Clinical impact</h4><p>The Duke 3-tiered system has been found to reduce the number of incidental thyroid nodules requiring further evaluation by nearly half compared with standard practice, with only 1% of potential (low-grade) malignancies missed <sup>14,16</sup>. There can be a measurement discordance between modalities (with CT/MRI +/- 4.7 mm compared to US), but without any missed malignancies applying the Duke 3-tiered system <sup>17</sup>.</p>
  • +</ul><h5>Risk of malignancy</h5><p>Despite the lower detection rate, around one-third of <sup>18</sup>FDG-PET-positive nodules will be malignant <sup>9</sup>. Rates of malignancy from other cross-sectional modalities (CT/MRI) only reach 12% in some studies <sup>8,11</sup>. Ultrasound is lower still at &lt;2% malignancy in a population-based study, illustrating the high proportion of benign nodules <sup>12</sup>.</p><p><a href="/articles/multinodular-goitre">Multinodular goitres</a> can have similar malignancy rates as solitary thyroid nodules <sup>1</sup>.</p><p>Thyroid nodules in younger patients have a higher risk of malignancy.</p><p>The incidence of thyroid cancer has increased in recent decades without a change in thyroid cancer mortality rates, suggesting an "epidemic of diagnosis" <sup>4</sup>.</p><h4>Management</h4><p>There is variable practice in radiologists' reporting of incidental thyroid nodules <sup>8,10</sup>. Professional organizations have developed recommendations in recent years to aid radiologists and other clinicians in their management.</p><h5>Incidental thyroid nodules on CT/MRI/PET</h5><p>CT, MRI, PET, and other nuclear medicine scans lack the spatial resolution to characterise suspicious features and do not perfectly agree with the size and number of nodules found on US <sup>16</sup>. Size on CT or MRI, however, can be used to stratify need for evaluation.</p><h6>American Thyroid Association recommendations</h6><p>The American Thyroid Association published its guidelines on thyroid nodule management in 2015, recommending <a href="/articles/assessment-of-thyroid-lesions-ultrasound">thyroid US</a> for all patients in whom another imaging study suggested the presence of a thyroid nodule <sup>13</sup>. The guidelines also state separately that in general, only nodules &gt;1 cm merit evaluation.</p><p>With the finding of a thyroid nodule &gt;1 cm, a serum thyroid-stimulating hormone (TSH, thyrotropin) level should also be obtained. If the level is low, a <a href="/articles/thyroid-scan-i-123">radionuclide thyroid scan</a> should be obtained.</p><p>The findings of these tests then help guide the need for fine needle aspiration, the most accurate method of evaluating thyroid nodules.</p><h6>American College of Radiology recommendations</h6><p>The <a href="/articles/american-college-of-radiology">American College of Radiology</a> Incidental Thyroid Findings Committee published a white paper in 2015 with recommendations based on the so-called 3-tiered system initially developed at Duke University <sup>14</sup>. A nodule meeting any of the following criteria is recommended for further evaluation by thyroid US:</p><ul>
  • +<li>focal thyroid uptake on FDG-PET or other nuclear medicine scans (e.g. <a href="/articles/octreotide-scintigraphy">octreotide</a>, <a href="/articles/tc-99m-sestamibi">sestamibi</a>)</li>
  • +<li>thyroid nodule with local tissue invasion</li>
  • +<li>thyroid nodule with <a href="/articles/cervical-lymph-node-metastasis-radiologic-criteria">suspicious lymph nodes</a> (enlarged, cystic, calcified, or hyperenhancing)</li>
  • +<li>thyroid nodule ≥1 cm (in axial plane) in patients &lt;35 years old</li>
  • +<li>thyroid nodule ≥1.5 cm (in axial plane) in patients ≥35 years old</li>
  • +</ul><p>When multiple thyroid nodules are present, the criteria apply to the largest nodule.</p><p>Patients who have limited life expectancy or serious comorbidities (that increase the risk of treatment or pose more risk to the patient than possible thyroid cancer) should not undergo further evaluation of incidental nodules lacking suspicion for local invasion or nodal metastases unless the patient or referring physician specifically requests so.</p><p>The Duke 3-tiered system has been found to reduce the number of incidental thyroid nodules requiring biopsy by one-third to nearly one-half compared with standard practices, with a false negative rate of 13% <sup>17-19</sup>.</p><h5>Incidental thyroid nodules on extrathyroidal ultrasound</h5><p>Per the American College of Radiology White Paper recommendations, the same size cutoffs used for nonsonographic imaging also apply for extrathyroidal ultrasound:</p><ul>
  • +<li>≥1.0 cm for age &lt;35 years</li>
  • +<li>≥1.5 cm for age ≥35 years.</li>
  • +</ul><p>Dedicated thyroid ultrasound would also be indicated if suspicious features happen to be captured on the nonthyroidal ultrasound, such as</p><ul>
  • +<li>microcalcifications</li>
  • +<li>marked hypoechogenicity</li>
  • +<li>lobulated/irregular margins</li>
  • +<li>taller-than-wide shape</li>
  • +</ul><p>The list of suspicious sonographic features been updated in the <a href="/articles/acr-thyroid-imaging-reporting-and-data-system-acr-ti-rads">ACR TI-RADS</a> 2017 publication <sup>15</sup>.</p>

References changed:

  • 16. Ní Mhuircheartaigh J, Siewert B, Sun M. Correlation Between the Size of Incidental Thyroid Nodules Detected on CT, MRI or PET-CT and Subsequent Ultrasound. Clin Imaging. 2016;40(6):1162-6. <a href="https://doi.org/10.1016/j.clinimag.2016.08.006">doi:10.1016/j.clinimag.2016.08.006</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/27569401">Pubmed</a>
  • 17. Bahl M, Sosa J, Eastwood J, Hobbs H, Nelson R, Hoang J. Using the 3-Tiered System for Categorizing Workup of Incidental Thyroid Nodules Detected on CT, MRI, or PET/CT: How Many Cancers Would Be Missed? Thyroid. 2014;24(12):1772-8. <a href="https://doi.org/10.1089/thy.2014.0066">doi:10.1089/thy.2014.0066</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/25203387">Pubmed</a>
  • 18. Nguyen X, Choudhury K, Eastwood J et al. Incidental Thyroid Nodules on CT: Evaluation of 2 Risk-Categorization Methods for Work-Up of Nodules. AJNR Am J Neuroradiol. 2013;34(9):1812-7. <a href="https://doi.org/10.3174/ajnr.A3487">doi:10.3174/ajnr.A3487</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/23557957">Pubmed</a>
  • 19. Hobbs H, Bahl M, Nelson R et al. Journal Club: Incidental Thyroid Nodules Detected at Imaging: Can Diagnostic Workup Be Reduced by Use of the Society of Radiologists in Ultrasound Recommendations and the Three-Tiered System? AJR Am J Roentgenol. 2014;202(1):18-24. <a href="https://doi.org/10.2214/AJR.13.10972">doi:10.2214/AJR.13.10972</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/24370125">Pubmed</a>
  • 16. Bahl M, Sosa JA, Eastwood JD, Hobbs HA, Nelson RC, Hoang JK. Using the 3-Tiered System for Categorizing Workup of Incidental Thyroid Nodules Detected on CT, MRI, or PET/CT: How Many Cancers Would Be Missed?. (2014) Thyroid. 24 (12): 1772-8. <a href="https://doi.org/10.1089/thy.2014.0066">doi:10.1089/thy.2014.0066</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/25203387">Pubmed</a> <span class="ref_v4"></span>
  • 17. Ní Mhuircheartaigh JM, Siewert B, Sun MR. Correlation between the size of incidental thyroid nodules detected on CT, MRI or PET-CT and subsequent ultrasound. (2016) Clinical imaging. 40 (6): 1162-1166. <a href="https://doi.org/10.1016/j.clinimag.2016.08.006">doi:10.1016/j.clinimag.2016.08.006</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/27569401">Pubmed</a> <span class="ref_v4"></span>

Updates to Synonym Attributes

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.